Health ❯Pharmaceuticals ❯Drug Development
Clinical Testing Inflammatory Bowel Disease Oral-Based Treatments
The acquisition aims to bolster Eli Lilly's pipeline with Morphic's experimental treatments for inflammatory bowel disease and other chronic conditions.
